Integrating artificial intelligence (AI) with electrochemical biosensors is revolutionizing medical treatments by enhancing patient data collection and enabling the development of advanced wearable sensors for health, fitness, and environmental monitoring. Electrochemical biosensors, which detect biomarkers through electrochemical processes, are significantly more effective. The integration of artificial intelligence is adept at identifying, categorizing, characterizing, and projecting intricate data patterns. As the Internet of Things (IoT), big data, and big health technologies move from theory to practice, AI-powered biosensors offer significant opportunities for real-time disease detection and personalized healthcare. Still, they also pose challenges such as data privacy, sensor stability, and algorithmic bias. This paper highlights the critical advances in material innovation, biorecognition elements, signal transduction, data processing, and intelligent decision systems necessary for developing next-generation wearable and implantable devices. Despite existing limitations, the integration of AI into biosensor systems shows immense promise for creating future medical devices that can provide early detection and improved patient outcomes, marking a transformative step forward in healthcare technology.
The electrochemical biosensor devices based on enzymes for monitoring biochemical substances are still considered attractive. We investigated the immobilization of glucose oxidase (GOx) on a new composite nanomaterial poly(3,4-ethylenedioxythiophene): polystyrene sulfonate (PEDOT:PSS)/titanium carbide,(Ti3C2)/graphene quantum dots(GQD) modified screen-printed carbon electrode (SPCE) for glucose sensing. The characterization and electrochemical behavior of PEDOT:PSS/Ti3C2/GQD towards the electrocatalytic oxidation of GOx was analyzed by FTIR, XPS, SEM, cyclic voltammetry (CV), and differential pulse voltammetry (DPV). This composite nanomaterial was found to tend to increase the electrochemical behavior and led to a higher peak current of 100.17 µA compared to 82.01 µA and 95.04 µA for PEDOT:PSS and PEDOT:PSS/Ti3C2 alone. Moreover, the detection results demonstrated that the fabricated biosensor had a linear voltammetry response in the glucose concentration range 0–500 µM with a relatively sensitivity of 21.64 µAmM−1cm−2 and a detection limit of 65 µM (S/N = 3), with good stability and selectivity. This finding could be useful as applicable guidance for the modification screen printed carbon (SPCE) electrodes focused on composite PEDOT:PSS/Ti3C2/GQD for efficient detection using an enzyme-based biosensor.